Risks and benefits of aromatase inhibitors in postmenopausal breast cancer
Risks and benefits of aromatase inhibitors in postmenopausal breast cancer Women on aromatase inhibitors are at a two- and four-fold increased risk of bone loss compared to a matched set of women in the general population, says a 2015 review in theJournal of Bone Oncology. Of these, persistent joint and muscle pain are the commonly […]
Risks and benefits of aromatase inhibitors in postmenopausal breast cancer Read More »